0001493152-24-027251.txt : 20240715
0001493152-24-027251.hdr.sgml : 20240715
20240715110935
ACCESSION NUMBER: 0001493152-24-027251
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240627
FILED AS OF DATE: 20240715
DATE AS OF CHANGE: 20240715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREEN DAVID
CENTRAL INDEX KEY: 0001008643
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35853
FILM NUMBER: 241116188
MAIL ADDRESS:
STREET 1: C/O HARVARD BIOSCIENCE INC
STREET 2: 84 OCTOBER HILL ROAD
CITY: HOLLISTON
STATE: MA
ZIP: 01746-1371
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
CENTRAL INDEX KEY: 0001563665
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 455210462
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
BUSINESS PHONE: (774) 233-7300
MAIL ADDRESS:
STREET 1: 84 OCTOBER HILL ROAD
STREET 2: SUITE 11
CITY: HOLLISTON
STATE: MA
ZIP: 01746
FORMER COMPANY:
FORMER CONFORMED NAME: Biostage, Inc.
DATE OF NAME CHANGE: 20160331
FORMER COMPANY:
FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc.
DATE OF NAME CHANGE: 20121204
4
1
ownership.xml
X0508
4
2024-06-27
0
0001563665
Harvard Apparatus Regenerative Technology, Inc.
HRGN
0001008643
GREEN DAVID
C/O HREGEN
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON
MA
01746
1
0
0
0
0
Stock Option (right to buy)
2.92
2024-06-27
4
A
0
10204
0
A
2034-06-27
Common Stock, par value $0.01 per share
10204
10204
D
Stock Option (right to buy)
2.92
2024-06-27
4
A
0
8215
0
A
2034-06-27
Common Stock, par value $0.01 per share
8215
8215
D
This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 27, 2024, December 27, 2024, March 27, 2025 and June 27, 2025.
This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2024, September 30, 2024 and December 31, 2024.
This form has been signed under power of attorney.
/s/ Joseph Damasio, by power of attorney
2024-07-15